All patients with HF regardless of EF benefit from SGLT2i - PACE-CME

All patients with HF regardless of EF benefit from SGLTi

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Is class I recommendation for aspirin use in CVD prevention too strong?
Is class I recommendation for aspirin use in CVD prevention too strong?
ESC 2022
Is class I recommendation for aspirin use in CVD prevention too strong?
- Prof. John Cleland, MD
Understanding the effects of ARNI in acute MI
Understanding the effects of ARNI in acute MI
ESC 2022
Understanding the effects of ARNI in acute MI
- Otavio Berwanger, MD, PhD
Unexpected findings when comparing DOAC with VKA in rheumatic AF
Unexpected findings when comparing DOAC with VKA in rheumatic AF
ESC 2022
Unexpected findings when comparing DOAC with VKA in rheumatic AF
- Prof. Ganesan Karthikeyan, MD
Meta-analysis on effects of statins on muscle symptoms
Meta-analysis on effects of statins on muscle symptoms
ESC 2022
Meta-analysis on effects of statins on muscle symptoms
- Prof. Colin Baigent